Home-based management of fever in rural Uganda: Community perceptions and provider opinions

Xavier Nsabagasani, Jesca-Nsungwa-Sabiiti, Karin Källander, Stefan Peterson, George Pariyo, Göran Tomson

Research output: Contribution to journalArticle

Abstract

Background. Uganda was the first country to scale up Home Based Management of Fever/Malaria (HBM) in 2002. Under HBM pre-packaged unit doses with a combination Sulphadoxine/Pyrimethamin (SP) and Chloroquine (CQ) called "HOMAPAK" are administered to all febrile children by community selected voluntary drug distributors (DDs). In this study, community perceptions, health worker and drug provider opinions about the community based distribution of HOMAPAK and its effect on the use of other antimalarials were assessed. Methods. In 2004, four focus group discussions with mothers and 11 key informant interviews with drug sellers, drug distributors and health workers were conducted in Kasese district, western Uganda. This was complemented by three months of field observations. Results. Caretakers concurred that they were benefiting from the programme. However, according to the information from the DDs and health workers, many caretakers perceived HOMAPAK as a drug of lower quality only meant for first aid. Caretakers also expressed need for other drugs to treat other childhood diseases. The introduction of HOMAPAKs was said not to affect the sale of other allopathic antimalarial drugs in the community. DDs expressed concerns about lack of incentives and facilitation such as torches, gumboots and diagnostic equipment to improve their performance. Conclusion. HBM is well appreciated by the community. However, more efforts are needed to improve uptake of the strategy through systematic community sensitization and community dialogue. This study highlights the potential of community based volunteers if well trained, facilitated and integrated into a functioning local health system.

Original languageEnglish (US)
Article number11
JournalMalaria Journal
Volume6
DOIs
StatePublished - 2007
Externally publishedYes

Fingerprint

Uganda
Rural Population
Fever
Pharmaceutical Preparations
Antimalarials
Health
Diagnostic Equipment
First Aid
Chloroquine
Focus Groups
Malaria
Motivation
Volunteers
Mothers
Interviews
Delivery of Health Care

ASJC Scopus subject areas

  • Parasitology
  • Infectious Diseases

Cite this

Nsabagasani, X., Jesca-Nsungwa-Sabiiti, Källander, K., Peterson, S., Pariyo, G., & Tomson, G. (2007). Home-based management of fever in rural Uganda: Community perceptions and provider opinions. Malaria Journal, 6, [11]. https://doi.org/10.1186/1475-2875-6-11

Home-based management of fever in rural Uganda : Community perceptions and provider opinions. / Nsabagasani, Xavier; Jesca-Nsungwa-Sabiiti; Källander, Karin; Peterson, Stefan; Pariyo, George; Tomson, Göran.

In: Malaria Journal, Vol. 6, 11, 2007.

Research output: Contribution to journalArticle

Nsabagasani, Xavier ; Jesca-Nsungwa-Sabiiti ; Källander, Karin ; Peterson, Stefan ; Pariyo, George ; Tomson, Göran. / Home-based management of fever in rural Uganda : Community perceptions and provider opinions. In: Malaria Journal. 2007 ; Vol. 6.
@article{059ce26afbe0466581c34df28a87367c,
title = "Home-based management of fever in rural Uganda: Community perceptions and provider opinions",
abstract = "Background. Uganda was the first country to scale up Home Based Management of Fever/Malaria (HBM) in 2002. Under HBM pre-packaged unit doses with a combination Sulphadoxine/Pyrimethamin (SP) and Chloroquine (CQ) called {"}HOMAPAK{"} are administered to all febrile children by community selected voluntary drug distributors (DDs). In this study, community perceptions, health worker and drug provider opinions about the community based distribution of HOMAPAK and its effect on the use of other antimalarials were assessed. Methods. In 2004, four focus group discussions with mothers and 11 key informant interviews with drug sellers, drug distributors and health workers were conducted in Kasese district, western Uganda. This was complemented by three months of field observations. Results. Caretakers concurred that they were benefiting from the programme. However, according to the information from the DDs and health workers, many caretakers perceived HOMAPAK as a drug of lower quality only meant for first aid. Caretakers also expressed need for other drugs to treat other childhood diseases. The introduction of HOMAPAKs was said not to affect the sale of other allopathic antimalarial drugs in the community. DDs expressed concerns about lack of incentives and facilitation such as torches, gumboots and diagnostic equipment to improve their performance. Conclusion. HBM is well appreciated by the community. However, more efforts are needed to improve uptake of the strategy through systematic community sensitization and community dialogue. This study highlights the potential of community based volunteers if well trained, facilitated and integrated into a functioning local health system.",
author = "Xavier Nsabagasani and Jesca-Nsungwa-Sabiiti and Karin K{\"a}llander and Stefan Peterson and George Pariyo and G{\"o}ran Tomson",
year = "2007",
doi = "10.1186/1475-2875-6-11",
language = "English (US)",
volume = "6",
journal = "Malaria Journal",
issn = "1475-2875",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Home-based management of fever in rural Uganda

T2 - Community perceptions and provider opinions

AU - Nsabagasani, Xavier

AU - Jesca-Nsungwa-Sabiiti,

AU - Källander, Karin

AU - Peterson, Stefan

AU - Pariyo, George

AU - Tomson, Göran

PY - 2007

Y1 - 2007

N2 - Background. Uganda was the first country to scale up Home Based Management of Fever/Malaria (HBM) in 2002. Under HBM pre-packaged unit doses with a combination Sulphadoxine/Pyrimethamin (SP) and Chloroquine (CQ) called "HOMAPAK" are administered to all febrile children by community selected voluntary drug distributors (DDs). In this study, community perceptions, health worker and drug provider opinions about the community based distribution of HOMAPAK and its effect on the use of other antimalarials were assessed. Methods. In 2004, four focus group discussions with mothers and 11 key informant interviews with drug sellers, drug distributors and health workers were conducted in Kasese district, western Uganda. This was complemented by three months of field observations. Results. Caretakers concurred that they were benefiting from the programme. However, according to the information from the DDs and health workers, many caretakers perceived HOMAPAK as a drug of lower quality only meant for first aid. Caretakers also expressed need for other drugs to treat other childhood diseases. The introduction of HOMAPAKs was said not to affect the sale of other allopathic antimalarial drugs in the community. DDs expressed concerns about lack of incentives and facilitation such as torches, gumboots and diagnostic equipment to improve their performance. Conclusion. HBM is well appreciated by the community. However, more efforts are needed to improve uptake of the strategy through systematic community sensitization and community dialogue. This study highlights the potential of community based volunteers if well trained, facilitated and integrated into a functioning local health system.

AB - Background. Uganda was the first country to scale up Home Based Management of Fever/Malaria (HBM) in 2002. Under HBM pre-packaged unit doses with a combination Sulphadoxine/Pyrimethamin (SP) and Chloroquine (CQ) called "HOMAPAK" are administered to all febrile children by community selected voluntary drug distributors (DDs). In this study, community perceptions, health worker and drug provider opinions about the community based distribution of HOMAPAK and its effect on the use of other antimalarials were assessed. Methods. In 2004, four focus group discussions with mothers and 11 key informant interviews with drug sellers, drug distributors and health workers were conducted in Kasese district, western Uganda. This was complemented by three months of field observations. Results. Caretakers concurred that they were benefiting from the programme. However, according to the information from the DDs and health workers, many caretakers perceived HOMAPAK as a drug of lower quality only meant for first aid. Caretakers also expressed need for other drugs to treat other childhood diseases. The introduction of HOMAPAKs was said not to affect the sale of other allopathic antimalarial drugs in the community. DDs expressed concerns about lack of incentives and facilitation such as torches, gumboots and diagnostic equipment to improve their performance. Conclusion. HBM is well appreciated by the community. However, more efforts are needed to improve uptake of the strategy through systematic community sensitization and community dialogue. This study highlights the potential of community based volunteers if well trained, facilitated and integrated into a functioning local health system.

UR - http://www.scopus.com/inward/record.url?scp=33847665706&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847665706&partnerID=8YFLogxK

U2 - 10.1186/1475-2875-6-11

DO - 10.1186/1475-2875-6-11

M3 - Article

C2 - 17257396

AN - SCOPUS:33847665706

VL - 6

JO - Malaria Journal

JF - Malaria Journal

SN - 1475-2875

M1 - 11

ER -